Sex-specific patterns and differences in dementia and Alzheimer’s disease using informatics approaches
January 4, 2016 Qualitative development and content validity of the non–small cell lung cancer symptom assessment questionnaire (NSCLC-SAQ), A patient-reported outcome instrument
January 4, 2016 Host-Directed Therapies for Infectious Diseases: Current Status, Recent Progress, and Future Prospects
January 4, 2016 Tuberculosis–Advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers
January 3, 2016 Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations
Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug Development
December 31, 2015 Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in Rats
Practical considerations for the use of clinical outcome assessments (COAs) in pediatric clinical research with examples from pediatric gastroenterology
